Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Akkermansia muciniphila has become an important factor in the study of ulcerative colitis (UC), serving both as a biomarker and as a potential candidate for next-generation probiotic therapy. Research from experimental models, clinical studies, and early translational investigations indicates that the presence, role, and therapeutic use of this bacterium can impact the development and progression of Ulcerative Colitis (UC) (1, 2, 3, 4).
Akkermansia muciniphila was dramatically reduced in patients with [ulcerative coliti…